Thursday, February 3, 2022
12:00PM – 1:35PM ET
Please note this virtual program is 12:00PM Eastern, 11:00AM Central, 10:00AM Mountain and 9:00AM Pacific.
Med Learning Group has designed this innovative, multi-format educational program; aimed at increasing HCP’s ability to: incorporate the latest clinical data into the treatment of patients with hemophilia and sickle cell disease, individualize management based on patient-specific factors, and incorporate a shared decision making and a multidisciplinary approach to patient care.
- Quality Improvement Personalized Posters: To proactively support more patient-centric care, an online poster portal will be available for all learners, where you can select images to create your own personalized practice poster, which will then be sent to you so that it can be hung in your practice setting. In addition to the physically printed posters, learners will also receive a PDF version via email to use during telehealth sessions. These posters will serve as an effective reminder of the education and the clinical pearls that were reviewed by the faculty. The images for these posters will be specifically designed to promote dialogue around evidence from clinical trials assessing available and emerging therapies for the treatment of patients with chronic hematologic conditions including hemophilia and SCD and evaluating patient-specific characteristics when developing individualized management plans.
- Whiteboard Animations – During the live activity, there will be an innovative learning experience incorporating whiteboard animations to supplement the didactic learning, to help learners better visualize the pathophysiology of hemophilia and sickle cell disease, as well as the mechanism of action of emerging therapies for the treatment of patients with hemophilia and SCD . Learners have access to downloadable whiteboard animations to view and share post-education. These animations have proven useful in engaging patients and caregivers in care and sharing education with participants’ colleagues.
Michael H. White, MD, MSc
Aflac Cancer & Blood Disorders Center
Children’s Healthcare of Atlanta
Assistant Professor of Pediatrics
Emory University School of Medicine
Martin H. Steinberg, MD
Professor, Hematology & Medical Oncology
Professor, Pathology & Laboratory Medicine
Boston University School of Medicine
After completing the activity, learners should be better able to:
- Evaluate evidence from clinical trials assessing available and emerging therapies for the treatment of patients with chronic hematologic conditions, including hemophilia and SCD
- Evaluate patient-specific characteristics when developing individualized management plans for those with chronic hematologic conditions, including hemophilia and SCD
- Facilitate a multidisciplinary patient-centered SDM approach to the management of those with chronic hematologic conditions, including hemophilia and SCD
This activity is designed to meet the educational needs of hematologists, emergency medicine physicians and other healthcare practitioners who treat patients with hemophilia A or B and SCD.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.50 AMA Category 1 Credit(s)TM.
Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSING CREDIT INFORMATION
This program would be beneficial for nurses involved in the care of patients with chronic hematologic conditions including hemophilia and SCD.
CNE Credits: 1.50 ANCC Contact Hour(s).
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.5 contact hour of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at firstname.lastname@example.org
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at email@example.com